FDA clears tumor segmentation software

The U.S. Food and Drug Administration (FDA) has cleared tumor segmentation software developed by Columbia University and licensed to Varian Medical Systems.

The software facilitates 3D lung tumor segmentation, and it has been incorporated into the Smart Segmentation module of Varian's Eclipse treatment planning system, the university said.

Page 1 of 460
Next Page